Cargando…
Options for empagliflozin in combination therapy in type 2 diabetes mellitus
OBJECTIVE: To update clinicians with an overview of empagliflozin for the treatment of type 2 diabetes mellitus (T2DM), with focus on use in combination regimens. METHODS: Keyword searches were conducted in the Medline database to identify literature reporting clinical trials of at least 12 weeks’ d...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888761/ https://www.ncbi.nlm.nih.gov/pubmed/27307761 http://dx.doi.org/10.2147/IJGM.S100288 |